Guirguis-Blake JM, Evans CV, Webber EM, et al. Screening for hypertension in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325(16):1657-1669.
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines [published correction appears in Hypertension. 2018; 71(6): e140–e144]. Hypertension. 2018;71(6):e13-e115.
Viera AJ, Hawes EM. Management of mild hypertension in adults. BMJ. 2016;355:i5719.
Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334-1357.
Ostchega Y, Fryar CD, Nwankwo T, et al. Hypertension prevalence among adults aged 18 and over: United States, 2017–2018. NCHS Data Brief. 2020(364):1-8.
Saeed A, Dixon DL, Yang E; American College of Cardiology. Racial disparities in hypertension prevalence and management: a crisis control? April 6, 2020. Accessed August 17, 2023. https://www.acc.org/latest-in-cardiology/articles/2020/04/06/08/53/racial-disparities-in-hypertension-prevalence-and-management
Chobanian AV, Bakris GL, Black HR, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003; 290(2): 197]. JAMA. 2003;289(19):2560-2572.
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) [published correction appears in JAMA. 2014; 311(17): 1809]. JAMA. 2014;311(5):507-520.
Krist AH, Davidson KW, Mangione CM, et al. Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2021;325(16):1650-1656.
Ogedegbe G, Pickering T. Principles and techniques of blood pressure measurement. Cardiol Clin. 2010;28(4):571-586.
Kronish IM, Hughes C, Quispe K, et al. Implementing ambulatory blood pressure monitoring in primary care practice. Fam Pract Manag. 2020;27(3):19-25.
Charles L, Triscott J, Dobbs B. Secondary hypertension: discovering the underlying cause. Am Fam Physician. 2017;96(7):453-461.
Langan R, Jones K. Common questions about the initial management of hypertension. Am Fam Physician. 2015;91(3):172-177.
Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014; 129(25 suppl 2): S74–S75]. Circulation. 2014;129(25 suppl 2):S49-S73.
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in Circulation. 2019; 139(25): e1182–1186]. Circulation. 2019;139(25):e1082-e1143.
Lloyd-Jones DM, Braun LT, Ndumele CE, et al. Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology [published correction appears in J Am Coll Cardiol. 2019; 73(24): 3234]. J Am Coll Cardiol. 2019;73(24):3153-3167.
Gordon M, Di Bartolo IM. Using race with caution in the ASCVD calculator [curbside consultation]. Am Fam Physician. 2021;104(3):292-294.
Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published corrections appear in Circulation. 2015; 131(4): e326 and Circulation. 2014; 129(25 suppl 2): S100–S101]. Circulation. 2014;129(25 suppl 2):S76-S99.
Appel LJ, Moore TJ, Obarzanek E, et al.; DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336(16):1117-1124.
Sacks FM, Svetkey LP, Vollmer WM, et al.; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344(1):3-10.
Yin X, Rodgers A, Perkovic A, et al. Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis. Heart. 2022;108(20):1608-1615.
Brand A, Visser ME, Schoonees A, et al. Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women. Cochrane Database Syst Rev. 2022(8):CD015207.
Lee LL, Mulvaney CA, Wong YKY, et al. Walking for hypertension. Cochrane Database Syst Rev. 2021(2):CD008823.
Igarashi Y, Nogami Y. Running to lower resting blood pressure: a systematic review and meta-analysis. Sports Med. 2020;50(3):531-541.
Stevens VJ, Obarzanek E, Cook NR, et al.; Trials for the Hypertension Prevention Research Group. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med. 2001;134(1):1-11.
Semlitsch T, Krenn C, Jeitler K, et al. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database Syst Rev. 2021(2):CD008274.
Day E, Rudd JHF. Alcohol use disorders and the heart. Addiction. 2019;114(9):1670-1678.
Roerecke M, Kaczorowski J, Tobe SW, et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017;2(2):e108-e120.
Acin MT, Rueda JR, Saiz LC, et al. Alcohol intake reduction for controlling hypertension. Cochrane Database Syst Rev. 2020(9):CD010022.
Carey RM, Whelton PK; 2017 ACC/AHA Hypertension Guideline Writing Committee. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Ann Intern Med. 2018;168(5):351-358.
National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. Updated March 18, 2022. Accessed August 17, 2023. https://www.nice.org.uk/guidance/ng136
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [published corrections appear in JAMA. 2004; 291(18): 2196 and JAMA. 2003; 289(2): 178]. JAMA. 2002;288(23):2981-2997.
Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
Fretheim A, Odgaard-Jensen J, Brørs O, et al. Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Med. 2012;10:33.
Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs—overview and meta-analyses. J Hypertens. 2015;33(7):1321-1341.
Fink HA, Ishani A, Taylor BC, et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians clinical practice guideline. Ann Intern Med. 2012;156(8):570-581.
Holt HK, Gildengorin G, Karliner L, et al. Differences in hypertension medication prescribing for Black Americans and their association with hypertension outcomes. J Am Board Fam Med. 2022;35(1):26-34.
Egan BM, Yang J, Rakotz MK, et al. Self-reported antihypertensive medication class and temporal relationship to treatment guidelines. Hypertension. 2022;79(2):338-348.
Flack JM, Buhnerkempe MG. Race and antihypertensive drug therapy: edging closer to a new paradigm [editorial]. Hypertension. 2022;79(2):349-351.
Fried LF, Emanuele N, Zhang JH, et al.; VA NEPHRON-D Investigators. Combined angiotensin inhibition for the treatment of diabetic nephropathy [published correction appears in N Engl J Med. 2014; 158: A7255]. N Engl J Med. 2013;369(20):1892-1903.
Yusuf S, Teo KK, Pogue J, et al.; ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547-1559.
Walters Kluwer. Lexicomp: evidence-based drug referential content. Accessed August 11, 2023. https://www.wolterskluwer.com/en/solutions/lexicomp
Coles S, Fisher L, Lin KW, et al. ColesSFisherLLinKWet alBlood pressure targets in adults with hypertension: a clinical practice guideline from the AAFP. Am Fam Physician2022; 106(6): online. Accessed August 17, 2023. https://www.aafp.org/pubs/afp/issues/2022/1200/practice-guidelines-aafphypertension-full-guideline.html
Wright JT, Williamson JD, Whelton PK, et al.; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control [published correction appears in N Engl J Med. 2017; 377(25): 2506]. N Engl J Med. 2015;373(22):2103-2116.
Reboussin DM, Allen NB, Griswold ME, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in Hypertension. 2018; 71(6): e145]. Hypertension. 2018;71(6):e116-e135.
Jaeger BC, Bress AP, Bundy JD, et al. Longer-term all-cause and cardiovascular mortality with intensive blood pressure control: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 2022;7(11):1138-1146.
Jones DW, Clark D, Hall ME. Blood pressure control after SPRINT— back to reality [comment]. JAMA Cardiol. 2022;7(11):1146-1147.
LeFevre M. ACC/AHA hypertension guideline: what is new? What do we do?. Am Fam Physician. 2018;97(6):372-373.
Sheppard JP, Stevens S, Stevens R, et al. Benefits and harms of antihypertensive treatment in low-risk patients with mild hypertension. JAMA Intern Med. 2018;178(12):1626-1634.
Arguedas JA, Leiva V, Wright JM. Blood pressure targets in adults with hypertension. Cochrane Database Syst Rev. 2020(12):CD004349.
Saiz LC, Gorricho J, Garjón J, et al. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Cochrane Database Syst Rev. 2022(11):CD010315.
Smetana GW, Beach J, Lipsitz L, et al. What should be the target blood pressure for this older patient with hypertension? Grand rounds discussion from Beth Israel Deaconess Medical Center. Ann Intern Med. 2018;169(3):175-182.
Weinfeld JM, Hart KM, Vargas JD. Home blood pressure monitoring [published correction appears in Am Fam Physician. 2022; 105(2): 115]. Am Fam Physician. 2021;104(3):237-243.
Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122(3):290-300.
Taler SJ. Initial treatment of hypertension. N Engl J Med. 2018;378(7):636-644.
Mills KT, Obst KM, Shen W, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis. Ann Intern Med. 2018;168(2):110-120.